Clinical trial
MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension
NCT02858791 is registered in ClinicalTrials.gov with Northwell Health as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- MIF- Thyroxine Interactions in the Pathogenesis of Pulmonary Arterial Hypertension
- Lead sponsor
- Northwell Health
- Phase
- Observational
- Overall status
- Completed
- Start date
- February 28, 2013
- Completion date
- December 21, 2017
- Enrollment
- 99 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
interstitial lung disease, pulmonary arterial hypertension, pulmonary hypertension